Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2012 Jan;113(1):3-12.
doi: 10.1002/jcb.23335.

Regulation of anti-apoptotic BCL2-proteins by non-canonical interactions: the next step forward or two steps back?

Affiliations
Review

Regulation of anti-apoptotic BCL2-proteins by non-canonical interactions: the next step forward or two steps back?

Levi J Beverly. J Cell Biochem. 2012 Jan.

Abstract

All aspects of cellular biology affect the process of regulated cell death, or apoptosis, and disruption of this process is a causative event in many diseases. Therefore, a comprehensive understanding of all pathways that regulate apoptosis would increase our knowledge of basic cellular functions, as well as the etiologies of many diseases. In turn, we may be able to use this knowledge to better treat patients with diseases, including cancer. Although the basic signaling pathway that regulates apoptosis has been known for over 10 years, we still have much to learn about the upstream signaling components that can directly regulate the core apoptosis machinery. The focus of this review will be to direct attention to non-canonical regulators of the BCL2-family of proteins, especially our void of understanding of such interactions, and the controversy that surrounds some such interactions.

PubMed Disclaimer

Similar articles

Cited by

MeSH terms

Substances

LinkOut - more resources